Press release
Infectious Disease Rapid Diagnostics Devices Market to Surpass USD 20.2 Billion by 2035 Driven by Point-of-Care Testing Demand and Global Health Preparedness - Analysis by TMR
Infectious Disease Rapid Diagnostics Devices Market
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86762
Growing Need for Early Detection and Pandemic Preparedness
Frequent outbreaks of emerging and re-emerging pathogens-including COVID-19, influenza variants, HIV, tuberculosis, and viral hepatitis-have reinforced the critical role of real-time diagnostics. Rapid tests enable early identification, isolation, and treatment decisions, helping reduce disease transmission and mortality.
Governments, global health organizations, and private sectors are heavily investing in diagnostic innovation and pandemic preparedness infrastructure, creating strong, sustained market opportunities.
Shift Toward Point-of-Care and Home-Based Testing
Technological advancements have significantly improved the accuracy, portability, and ease of use of rapid diagnostic devices. The growing adoption of point-of-care (POC) and at-home test kits allows healthcare providers and consumers to make quick decisions without waiting for centralized lab results.
Key advances include:
Microfluidic and lab-on-chip platforms
Molecular point-of-care PCR systems
AI-enabled test interpretation
Smartphone-integrated diagnostics
Multiplex testing for simultaneous pathogen detection
These innovations are reducing testing complexity while broadening access in low-resource and rural settings.
Market Drivers: Rising Disease Prevalence and Technological Innovation
High global incidence of viral and bacterial infections
Increased public awareness and testing frequency post-COVID-19
Growth of home healthcare and telemedicine
Government funding for surveillance and emergency response
Faster regulatory approvals for essential medical devices
Furthermore, demand for antimicrobial resistance (AMR) diagnostics is surging as clinicians seek rapid tools to ensure appropriate treatment decisions.
Key Applications of Rapid Diagnostics
Respiratory Infections (e.g., COVID-19, influenza, RSV)
Sexually Transmitted Infections (HIV, HPV, chlamydia, gonorrhea)
Gastrointestinal Diseases (norovirus, C. difficile)
Tropical & Vector-borne Diseases (dengue, malaria)
Hospital-acquired Infections
Blood Screening and Sepsis
Molecular diagnostics represent the fastest-growing segment, attributed to high sensitivity and adoption in decentralized healthcare models.
Challenges: Pricing and Quality Assurance
Cost sensitivity, particularly in low-income regions, and quality assurance concerns remain constraints. Inaccurate or substandard tests can hinder disease control efforts. International agencies such as WHO are intensifying regulatory and validation efforts, improving trust in rapid diagnostics.
Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/infectious-disease-rapid-diagnostics-devices-market.html
Competitive Landscape
The infectious disease rapid diagnostics devices market is highly competitive and innovation-driven, with leading players focusing on molecular POC systems, data connectivity, and expanded test menus.
Prominent companies include:
F. Hoffmann-La Roche AG
Abbott
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company (BD)
bioMérieux SA
Diasorin S.p.A.
Hologic, Inc.
QuidelOrtho Corporation
Siemens Healthineers AG
Seegene Inc.
QIAGEN
Danaher Corporation
Trinity Biotech
Grifols
These companies continue to expand through R&D investment, strategic collaborations, and enhanced manufacturing capacities.
Regional Market Outlook
North America maintains a leading share due to advanced healthcare infrastructure and high R&D investment.
Europe shows strong demand through national screening programs and public health initiatives.
Asia-Pacific is the fastest-growing region, driven by rapid urbanization, infectious disease prevalence, and expanding POC accessibility in India, China, and Southeast Asia.
Africa and Latin America continue to receive major investments from global health organizations for infectious disease control.
Future Outlook: Toward Smart, Connected, and Preventive Diagnostics
The next decade will transform rapid diagnostics into a digital-connected ecosystem enabling real-time disease surveillance and personalized healthcare. Growth will be further propelled by:
Smart diagnostics integrated with telehealth platforms
AI-driven data analytics for outbreak monitoring
Expansion into emerging markets with localized manufacturing
Rapid tests for AMR and novel pathogens
As global health strategies shift toward early detection and prevention, rapid diagnostic devices will remain a cornerstone of infectious disease management through 2035 and beyond.
More Trending Reports by Transparency Market Research -
Multiomics Market: https://www.transparencymarketresearch.com/multiomics-market.html
Brain Imaging Devices Market: https://www.transparencymarketresearch.com/brain-imaging-devices-market.html
Animal Model Market: https://www.transparencymarketresearch.com/animal-model-market.html
Surgical Site Infection (SSI) Market: https://www.transparencymarketresearch.com/surgical-site-infection-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Rapid Diagnostics Devices Market to Surpass USD 20.2 Billion by 2035 Driven by Point-of-Care Testing Demand and Global Health Preparedness - Analysis by TMR here
News-ID: 4256722 • Views: …
More Releases from Transparency Market Research
Data Center Cooling Market Expected to Hit US$ 73.4 Billion by 2035 with Rising …
The global Data Center Cooling Market is projected to reach US$ 73.4 Billion by 2035, expanding at a CAGR of 11.9% from 2025 to 2035, driven by the surging adoption of cloud computing, artificial intelligence (AI), and high-performance computing (HPC). As data centers become denser and more power-intensive, the demand for energy-efficient and sustainable cooling technologies such as liquid cooling, immersion cooling, and AI-driven thermal management systems is accelerating.
The…
Freight Forwarding Market to Surpass US$ 364.2 Billion by 2035, Driven by Trade …
The global freight forwarding market is entering a transformative decade as international trade expansion, supply chain digitization, and sustainability initiatives reshape the global logistics landscape. Valued at US$ 215.5 billion in 2024, the market is projected to grow at a CAGR of 4.9% from 2025 to 2035, reaching an estimated US$ 364.2 billion by 2035. This growth underscores the critical role of freight forwarders in ensuring efficient, flexible, and resilient…
Football Merchandise Market to Reach USD 21.4 Billion by 2035 Driven by Fan Enga …
The global football merchandise market is gaining remarkable momentum as football continues to strengthen its position as the world's most popular sport. Valued at US$ 11.5 billion in 2024, the market is projected to expand at a CAGR of 5.9% from 2025 to 2035, reaching approximately US$ 21.4 billion by 2035. Growth is being fueled by the increasing global fan base, rising spending on sports apparel, and the commercialization of…
Artificial Intelligence in Operating Room Market to Reach Over $10.9 Billion by …
The global artificial intelligence in operating room market is entering a transformative era as hospitals rapidly adopt digital surgery tools, real-time analytics, and autonomous support systems to improve patient outcomes. Valued at US$ 412.8 million in 2024, the market is projected to witness explosive growth at a CAGR of 34.7% from 2025 to 2035, ultimately crossing US$ 10.9 billion by 2035. Demand is accelerating as healthcare providers shift toward intelligent…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
